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Abstract 
Background: Aurones are naturally occurring compounds that belong to flaveno-
ids family and have antiplasmodial effects. This study investigated some new au-
rones derivatives against chloroquine sensitive Plasmodium falciparum. Here we report 
the synthesis, in vitro antiplasmodial activity and cytotoxic evaluation of 11 com-
pound from derivatives of (Z)-2- benzylidene-4, 6-dimethoxybenzofuran-3(2H)-
one. 
Methods: The cytotoxic evaluations of active compounds were performed with 
MTT (3-[4, 5-dimethylthiazol-2-yl]-2, 5 diphenyltetrazolium bromide) assay on hu-
man breast cancer cell lines; MCF7 and T47D. 
Results: From 11 compounds M3, M6 and M7 compounds showed good anti-
plasmodial effect against chloroquine-sensitive 3D strain of P. falciparum with IC50 
(50% inhibitory concentration) values of 7.82, 7.27 and 2.3 µM respectively. No 
noticeable toxicity was observed with these compounds when tested against tested 
cell lines.  
Conclusion: The replacement of the 4 and 5 positions at ring B of aurone deriva-
tives, with propoxy and bromide (Br) respectively was revealed highly advantageous 
for their antiplasmodial effect. 
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Introduction 
 
alaria is an infectious disease that 
caused by Plasmodium species (1). 
Plasmodium falciparum, P. vivax, P. ma-
larie, P. ovale, and P. knowlesi have been known 
as causes of human malaria (2-3). The most 
severe and deadly form of disease is caused by 
P. falciparum subspecies that causes the death of 
1% of patients (2). According to WHO Malaria 
Report 2012, there was an approximately 219 
million cases of malaria all around the world 
and 660,000 people died from this disease (4).  
Nowadays after AIDS and tuberculosis, ma-
laria is the most important human diseases. 
Unfortunately, despite using different methods 
for eradication or control of malaria, this dis-
ease is endemic in many tropical and subtropi-
cal countries (about 104 countries worldwide). 
Developing and spreading multidrug-resistant 
strains of P. falciparum, developing resistance in 
malaria vectors to the usual effective insecti-
cides and unsuccessfulness in developing an 
effective and inexpensive vaccine are the most 
important reasons of failure in malaria eradica-
tion or control programs (4).  
Today artemisinin-based combination thera-
py is the last defense against the malaria but 
there are some reports about the resistance 
against atremisinin and its derivatives (5). Fur-
thermore, these drugs are too expensive for 
widespread use (6). Therefore, we need effec-
tive and inexpensive drugs to replace chloro-
quine, which was the main stay of chemothe-
rapy of malaria for more than 50 years.  
Aurones (2-benzylidenbenzofuran-3(2H)-
ones), are secondary metabolite belonging to 
the flavonoids family and have an important 
role for the pigmentation of flowers in which 
they are found (7). They are structural isomers 
of flavones and there are reports about their 
inhibitory effects on erythrocytic stages of P. 
falciparum strains in vitro (8-10). Other effects 
of aurones are antileshmanial (11-12), trypano-
cidal (13), antiviral, and antifungal effects (7).  
The aim of this study was to investigate au-
rones analogs in order to find new drug candi-
dates against malaria. 
 
Materials and Methods 
 
Chemicals 
Reagents and materials obtained from Merck 
(Darmstadt, Germany) and Sigma Aldrich 
(Steinheim, Germany), and DMSO was pur-
chased from Fluka (Steinheim, Germany) and 
RPMI 1640 medium from Gibco-Invitrogen 
(Paisley, Scotland, UK). 
 
Tested compounds 
Synthesis of these compounds has been de-
scribed previously (10, 14-15). The basic struc-
ture of aurones derivatives is indicated in Fig. 
1. The structures of synthesized aurones have 
been shown in Table 1. 
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Fig. 1: Basic structures of aurones derivatives 
 
Parasite Culture 
The P. falciparum strain used in this study was 
3D7 chloroquine (CQ) sensitive. In vitro cul-
ture of P. falciparum was carried out according 
to the method described by Trager and Jensen 
with some modifications (16-18). Parasites 
were maintained in continuous culture on 
human erythrocytes (blood group O+), pro-
vided by the Blood Transfusion Organization 
(Zanjan, Iran), in RPMI 1640 medium with 
5% of human AB+ serum, 0.3 g/100 mL Al-
bumax I , 25 mM HEPES , 19 mM sodium 
M 
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carbonate and 30 µg/mL gentamicin sulfate at 
pH 7.2. The growth medium was replaced dai-
ly, and cultures were gassed with a mixture of 
91% N2, 6% CO2, and 3% O2. Synchroniza-
tion to the ring stage was achieved by sorbitol 
method (19). 
 
Table 1: the structure of synthesized aurones derivatives 
 
Compound R1 R2 R3 R4 R5 
M1 OMe OMe OMe OMe Br 
M2 OMe OMe OMe OMe OMe 
M3 OMe OMe - OMe OMe 
M4 OMe OMe OMe OH Cl 
M5 OMe OMe OMe OH Br 
M6 OMe OMe OMe OEt Br 
M7 OMe OMe OMe OPr Br 
M8 - - OMe OMe Cl 
M9 - - OMe OMe Br 
M10 - - OMe OH Cl 
M11 - - OMe OH Br 
 
In vitro antimalarial tests 
Compounds were prepared in DMSO at 
concentration of 10 mg/mL and serially di-
luted with culture medium to reach 1mg/mL 
before use. Twenty µL of 2-fold dilution series 
(50 - 0.3906 µg/mL) of compounds prepared 
in assay medium and added to each well of 96-
well plates in triplicate. One hundred eighty 
µL of synchronous P. falciparum culture (1% 
parasitemia and 2% hematocrit) added to each 
well reaching a final volume of 200 µL per 
well. Plates were incubated at 37o C for 24 h. 
Chloroquine was used as positive control and 
parasitized erythrocytes without drug were 
used as negative control. After 24 h incubation, 
Giemsa stained thin smears were made and 
parasitemia was confirmed by the numeration 
of 1000 erythrocytes (20). Data were imported 
in SPSS 16.0 software and IC50 values were 
calculated by means of Finney’s Probit analy-
sis (21).  
 
In vitro cytotoxicity assay 
The toxic effects of active compounds 
against P. falciparum were assessed on human 
breast cancer cell lines (MCF7 and T47D) by 
using MTT (3-[4, 5-dimethylthiazol-2-yl] -2, 5 
diphenyltetrazolium bromide) assay (22-23) 
and results were compared with untreated 
control. The cells were cultured in RPMI 1640 
medium containing 10% FBS (Fetal Bovine 
Serum) and incubated at 37o C with 5% CO2 
and 96% humidity. After several subcultures, 
cells were distributed in 96-well plates at 1,000 
cells in 100 µL of culture medium and incu-
bated for 24 h at same condition to allow at-
tachment of cells to the bottom of wells. Then 
culture medium removed and 100 µL of the 
same medium containing the drugs at various 
concentrations (100, 30, 10, 3, 1, 0.1 µM) add-
ed to each well in triplicate. Plates further in-
cubated for 5 days in same condition. The last 
column of plate containing 1000 cells in100 
µL of culture medium was regarded as control. 
After 5 days incubation the drug-containing 
medium discharged. For evaluation of cell 
survival, 25 µL of MTT solution (4 mg/mL in 
PBS) added to each well and plates incubated 
for 3 h (in same condition). Then 100 µL of 
DMSO added to each well and plates were 
gently shaken to dissolve the formed forma-
zan crystals. The absorbance of each well 
measured at 540 nm using an ELISA plate 
reader (Infinite M200, Tecan). The GI% 
(Growth Inhibition percent) was calculated 
using the formula; %Growth Inhibition = 100 
– (ODtest - ODcontrol) × 100, where ODtest is the 
mean absorbance of treated cells and ODcontrol 
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is the mean absorbance of a negative control. 
The cell survival of control assumed 100% 
and IC50values generated from dose-response 
curves for each cell line.  
 
Results 
 
In vitro antiplasmodial activity  
All the 11 compounds screened for in vitro 
antiplasmodial activity against the CQ-
sensitive (3D7) P. falciparum strain (Table 2). 
Of 11 compounds tested, 3 compounds had 
better antiplasmodial activity. Compound M7 
showed significant antiplasmodial activity with 
IC50 value of 2.3 µM. Compounds M3 and M6 
also showed good antiplasmodial activity with 
IC50 values of 7.82 and 7.27 µM respectively. 
The rest of compounds did not show noticea-
ble antiplasmodial activity.  
 
In vitro cytotoxicity assay 
Cytotxicity of compounds with IC50 value 
less than 50 µM assessed on MCF7 and T47D 
cell lines. Results of toxicity activity of the 
tested compounds and selectivity index (SI) 
are shown in Table 2. The SI is defined as the 
ratio of the toxicity to the antiplasmodial ac-
tivity and the higher selectivity should offer 
the potential of safer therapy. 
The M7 compound had high selectivity for 
P. falciparum than studied cell lines in compari-
son with other compounds (P = 0.008). 
 
Table 2: Antiplasmodial activity and toxicity assessment of tested compounds 
 
Compound P. falciparum 
IC50 (µM) 
MCF7 
IC50 (µM) 
T47D 
IC50 (µM) 
SI for 
MCF7 
SI for 
T47D 
M1 22.29 36.34 28.85 1.63 1.29 
M2 ≥50 - - - - 
M3 7.82 20.80 3.15 2.65 0.4 
M4 ≥50 - - - - 
M5 28.64 34.75 19.39 1.21 1.21 
M6 7.27 29.90 9.35 4.11 1.28 
M7 2.3 17.19 11.65 7.47 5.06 
M8 22.04 20.60 9.07 0.93 0.41 
M9 32.32 34.99 29.47 1.08 0.91 
M10 36.38 20.27 11.72 0.55 0.55 
M11 ≥50 - - - - 
CQ 0.775 - - - - 
 
Discussion 
 
Several studies have been done concerning 
the aurones as chemotherapeutic antimala-
rial agents (8-10). Aurones [2-benzylide-
nebenzofuran-3(2H)-ones] are natural com-
pounds belong to the flavonoids family. The 
natural entity of aurones, their inhibitory activ-
ity on Leishmania and malaria parasites (8, 24-
25), has prompted us to investigate aurones 
analogs in order to gather more structural 
elements required for the antiplasmodial 
activity. 
Three out of 11 compounds (M3, M6 and 
M7) showed good antiplasmodial activity with 
IC50 values of 7.82, 7.27 and 2.3 µM against 
3D7 starin of P. falciparum respectively. The 
M7 compound had better selectivity index 
than other two active compound (with SI 
value of 7.47 and 5.06 for MCF7 and T47D 
cell lines respectivly). This let us believe that 
activity obtained with this compound is not 
due to general toxicity against P. falciparum but 
can be explained by specific anti-plasmodial 
activity andshould offer potential for safer 
therapy.  
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In one study a library comprising 44 differ-
ent substituted aurones derivatives was syn-
thesized and screened against the chloroquine 
resistant P. falciparum W2 strain and demon-
strated that some compounds showed anti-
plasmodial activity in micromolar range (10). 
“A series of naturally occurring aurones was 
synthesized and evaluated for their ability to 
inhibit erythrocytic stages of P. falciparum 
strains in vitro” (8). The most active com-
pound was 4,6,4'-triacetyl-3',5'-dimethoxy-2-
aurone with IC50 values of 0.007 µM and 0.18 
µM for the P. falciparum strains K1 and NF54, 
respectively.  
According to previous investigations, the 
structure activity relationship confirmed that 
methoxylation at 4 and 6 carbons were benefi-
cial for antiplasmodial activity of aurones de-
rivatives (9). In our study, these substitutions 
were confirmed (compound M1 versus M9 
and M5 versus M11). This substitution pattern 
involved in binding of aurones derivatives to 
protozoal target protein ATP-binding cassette 
(ABC) transporters like P-glycoprotein (26-27). 
At the ring B, presence of a hydrophobic 
group was highly beneficial for antiplasmodial 
effect as illustrated by comparing derivatives 
M6 versus M5 and M9 versus M11. The elon-
gation of chain from methoxy to ethoxy and 
then to propoxy leads to an increase in anti-
plasmodial effect (compound M1 versus M6 
and M7). The presence of a hydrophobic ha-
logen atom at the ring B at 5 positions was 
quite beneficial as illustrated by comparing 
derivatives M1 and M2. In conclusion, 
throughout the present study, we report the 
preliminary results regarding the structural 
requirements for the antiplasmodial activity of 
aurones. We have found that the replacement 
of the 4 and 5 positions at ring B with pro-
poxyand bromide (Br) respectively was re-
vealed to be highly advantageous for the activ-
ity. We also optimized (at least in part) the na-
ture of substituents to be present at the A and 
B-rings.  
 
Conclusion 
 
The present results bring essential elements, 
which will be used, for the synthesis of more 
active aurones against malaria parasite. Further 
studies need to confirm the in vivo antiplas-
modial properties of active aurones derivatives 
against rodent malaria. 
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